×
About 1,045 results

ALLMedicine™ Brachytherapy Center

Research & Reviews  407 results

A comparative study of patient-reported outcomes after contemporary radiation technique...
https://doi.org/10.1016/j.radonc.2022.04.025
Radiotherapy and Oncology : Journal of the European Socie... Helou J, Morton G et. al.

May 3rd, 2022 - We aim to compare health-related quality of life (HRQoL) deterioration at 12 months in low-and intermediate-risk prostate cancer (PCa) patients treated with stereotactic ablative radiotherapy (SABR), high dose-rate brachytherapy (HDR) monotherapy ...

Does the addition of radiation improve survival compared to chemotherapy alone in women...
https://doi.org/10.1016/j.ygyno.2022.04.007
Gynecologic Oncology; Barrington DA, Fox B et. al.

Apr 27th, 2022 - To evaluate whether the addition of radiation to adjuvant chemotherapy is associated with improved survival in women with stage IV endometrial cancer following surgery. The National Cancer Database (NCDB) and Surveillance, Epidemiology, and End Re...

PSMA-PET- and MRI-based focal dose escalated radiotherapy of primary prostate cancer: p...
https://doi.org/10.1016/j.ijrobp.2022.04.020
International Journal of Radiation Oncology, Biology, Phy... Zamboglou DC, Spohn DSKB et. al.

Apr 27th, 2022 - The bi-centric XXX phase II trial investigates the implementation of molecular imaging with positron-emission tomography targeting prostate-specific-membrane-antigen (PSMA-PET) into modern focal dose-escalation radiotherapy (RT) concepts in 2 non-...

I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-li...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004002
Journal of Cardiothoracic Surgery; Chen ZK, Fan J et. al.

Apr 14th, 2022 - Continuing therapy for aggressive non-small-cell lung cancer (NSCLC) after first-line treatment (FLT) is challenging. The clinical efficacy of second-line chemotherapy (SLCT) for progressive NSCLC is limited. In this meta-analysis, we aim to evalu...

Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996640
Radiation Oncology (London, England); Tsumura H, Tanaka N et. al.

Apr 13th, 2022 - We compared the oncological outcomes of patients who received seed brachytherapy (SEED-BT) with those who received radical prostatectomy (RP) for intermediate-risk prostate cancer. Candidates were patients treated with either SEED-BT (n = 933) or ...

see more →

News  11 results

Radiation Therapy, Brachytherapy Outcomes Similar for Localized Prostate Cancer
https://www.medscape.com/viewarticle/938756

Oct 8th, 2020 - NEW YORK (Reuters Health) - Long-term survival among men with intermediate-risk prostate cancer did not differ regardless of whether they received stereotactic body radiation therapy (SBRT), dose-escalated external beam radiation (DE-EBRT) or brac...

Radiation Therapy, Brachytherapy Outcomes Similar for Localized Prostate Cancer
https://www.staging.medscape.com/viewarticle/938756

Oct 8th, 2020 - NEW YORK (Reuters Health) - Long-term survival among men with intermediate-risk prostate cancer did not differ regardless of whether they received stereotactic body radiation therapy (SBRT), dose-escalated external beam radiation (DE-EBRT) or brac...

In High-Risk Endometrial Cancer, Adding Chemo No Help, but…
https://www.staging.medscape.com/viewarticle/886383

Oct 2nd, 2017 - SAN DIEGO — In women with early-stage, high-risk endometrial cancer, adding chemotherapy to radiation therapy was not superior to the standard treatment of radiation alone, according to new findings. In a head-to-head trial of two adjuvant strateg...

In High-Risk Endometrial Cancer, Adding Chemo No Help, but…
https://www.medscape.com/viewarticle/886383

Oct 2nd, 2017 - SAN DIEGO — In women with early-stage, high-risk endometrial cancer, adding chemotherapy to radiation therapy was not superior to the standard treatment of radiation alone, according to new findings. In a head-to-head trial of two adjuvant strateg...

High-Dose-Rate Brachytherapy in Prostate Cancer: What Role?
https://www.medscape.com/viewarticle/852435

Oct 16th, 2015 - Hello. I am Dr Gerald Chodak for Medscape. Today, I want to talk about high-dose-rate temporary brachytherapy (HDRTB) for men with high-risk prostate cancer. I came across an article on Prostate Cancer Infolink that cited three randomized trials r...

see more →